CYT-014-GIPQb

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCYT-014-GIPQb
Drug Alias NameImmunodrug vaccines (Cytos)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionGlucose-Dependent Insulinotropic Polypeptide Receptor modulators
TargetsGlucose-Dependent Insulinotropic Polypeptide Receptor
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKuros Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKuros Biosciences
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A